基于捐赠者-接受者非HLA基因型不匹配的急性排斥的多基因风险评分
Rui Cao1, David P Schladt2, Casey Dorr2,3
1Division of Biostatistics and Health Data Science, School of Public Health, University of Minnesota, Minneapolis, Minnesota, United States of America.
PloS one
|May 31, 2024
概括
人类白细胞抗原 (HLA) 外的遗传不匹配显著影响移植急性排斥 (AR). 这项研究开发了非HLA遗传变异的多基因风险评分 (PRS),改善了捐赠者-接受者匹配,并可能降低AR风险.
科学领域:
- 遗传学 是一个遗传学.
- 移植免疫学 移植免疫学
- 基因组医学是一种基因组医学.
背景情况:
- 急性排斥 (AR) 是移植后的一个主要并发症.
- 目前的捐赠者-接受者匹配主要集中在血型和人类白细胞抗原 (HLA) 上.
- 非HLA基因不匹配在移植后并发症中的作用仍然在很大程度上未被探索.
研究的目的:
- 为了研究非HLA基因不匹配和脏移植接受者的急性排斥 (AR) 之间的联系.
- 开发和验证非HLA基因变异的多基因风险评分 (PRS),以预测AR风险.
主要方法:
- 全基因组扫描HLA和非HLA区域在784个活体捐赠者-接受者对的大量队列中.
- 使用单核酸多态 (SNPs) 使用严格的过标准构建非HLA PRS.
- 在352个活体捐赠者-接受者对的独立队列中验证PRS.
主要成果:
- 确定了一个与AR风险相关的显著SNP (rs6749137) (HR = 2.49,P = 2.15×10-8).
- 经验证的非HLA PRS在独立队列中与AR显著相关 (HR = 1.54,P = 0.019).
- 途径分析揭示了与PRS基因相关的显著生物过程,包括细胞形态发生,与PRS基因相关.
结论:
- 非HLA基因不匹配在移植结果中起着至关重要的作用.
- 开发的PRS可以有助于改进捐赠者-接受者遗传匹配算法.
- 需要进一步的研究来阐明PRS中的特定SNP的功能,并完善预测模型.
相关概念视频
Tissue Transplantation
358
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
358
Bone Marrow Sampling and Transplants
324
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
324
Cell-mediated Immune Responses
68.1K
Overview
68.1K


